Next Article in Journal
Metabolic Pathways of Leishmania Parasite: Source of Pertinent Drug Targets and Potent Drug Candidates
Next Article in Special Issue
The Current State of the Art in PARP Inhibitor-Based Delivery Nanosystems
Previous Article in Journal
Real-Life Therapeutic Concentration Monitoring of Long-Acting Cabotegravir and Rilpivirine: Preliminary Results of an Ongoing Prospective Observational Study in Switzerland
Previous Article in Special Issue
Sustainable Release of Propranolol Hydrochloride Laden with Biconjugated-Ufasomes Chitosan Hydrogel Attenuates Cisplatin-Induced Sciatic Nerve Damage in In Vitro/In Vivo Evaluation
 
 
Review

Article Versions Notes

Pharmaceutics 2022, 14(8), 1589; https://doi.org/10.3390/pharmaceutics14081589
Action Date Notes Link
article pdf uploaded. 30 July 2022 09:51 CEST Version of Record https://www.mdpi.com/1999-4923/14/8/1589/pdf-vor
article xml file uploaded 10 August 2022 09:37 CEST Original file -
article xml uploaded. 10 August 2022 09:37 CEST Update https://www.mdpi.com/1999-4923/14/8/1589/xml
article pdf uploaded. 10 August 2022 09:37 CEST Updated version of record https://www.mdpi.com/1999-4923/14/8/1589/pdf
article html file updated 10 August 2022 09:38 CEST Original file -
article html file updated 10 August 2022 10:00 CEST Update -
article html file updated 13 August 2022 04:43 CEST Update https://www.mdpi.com/1999-4923/14/8/1589/html
Back to TopTop